Literature DB >> 25100477

Neurodegeneration: Alzheimer's disease under strain.

Adriano Aguzzi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25100477     DOI： 10.1038/512032a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  15 in total

1.  An analytical solution to the kinetics of breakable filament assembly.

Authors:  Tuomas P J Knowles; Christopher A Waudby; Glyn L Devlin; Samuel I A Cohen; Adriano Aguzzi; Michele Vendruscolo; Eugene M Terentjev; Mark E Welland; Christopher M Dobson
Journal:  Science       Date:  2009-12-11       Impact factor: 47.728

2.  Cell biology: Beyond the prion principle.

Authors:  Adriano Aguzzi
Journal:  Nature       Date:  2009-06-18       Impact factor: 49.962

3.  Eight prion strains have PrP(Sc) molecules with different conformations.

Authors:  J Safar; H Wille; V Itri; D Groth; H Serban; M Torchia; F E Cohen; S B Prusiner
Journal:  Nat Med       Date:  1998-10       Impact factor: 53.440

4.  Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice.

Authors:  Jan Stöhr; Carlo Condello; Joel C Watts; Lillian Bloch; Abby Oehler; Mimi Nick; Stephen J DeArmond; Kurt Giles; William F DeGrado; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

5.  Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation.

Authors:  H Fraser; A G Dickinson
Journal:  J Comp Pathol       Date:  1973-01       Impact factor: 1.311

6.  Strain fidelity of chronic wasting disease upon murine adaptation.

Authors:  Christina J Sigurdson; Giuseppe Manco; Petra Schwarz; Pawel Liberski; Edward A Hoover; Simone Hornemann; Magdalini Polymenidou; Michael W Miller; Markus Glatzel; Adriano Aguzzi
Journal:  J Virol       Date:  2006-10-04       Impact factor: 5.103

7.  Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides.

Authors:  Georg Meisl; Xiaoting Yang; Erik Hellstrand; Birgitta Frohm; Julius B Kirkegaard; Samuel I A Cohen; Christopher M Dobson; Sara Linse; Tuomas P J Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-17       Impact factor: 11.205

8.  Prion strain discrimination using luminescent conjugated polymers.

Authors:  Christina J Sigurdson; K Peter R Nilsson; Simone Hornemann; Giuseppe Manco; Magdalini Polymenidou; Petra Schwarz; Mario Leclerc; Per Hammarström; Kurt Wüthrich; Adriano Aguzzi
Journal:  Nat Methods       Date:  2007-11-18       Impact factor: 28.547

9.  A change in the conformation of prions accompanies the emergence of a new prion strain.

Authors:  David Peretz; R Anthony Williamson; Giuseppe Legname; Yoichi Matsunaga; Julie Vergara; Dennis R Burton; Stephen J DeArmond; Stanley B Prusiner; Michael R Scott
Journal:  Neuron       Date:  2002-06-13       Impact factor: 17.173

10.  Molecular structure of β-amyloid fibrils in Alzheimer's disease brain tissue.

Authors:  Jun-Xia Lu; Wei Qiang; Wai-Ming Yau; Charles D Schwieters; Stephen C Meredith; Robert Tycko
Journal:  Cell       Date:  2013-09-12       Impact factor: 41.582
View more
  11 in total

1.  Facing up to Complexity: Implications for Our Social Experiments.

Authors:  Ronnie Hawkins
Journal:  Sci Eng Ethics       Date:  2015-06-11       Impact factor: 3.525

Review 2.  Spreading of pathology in neurodegenerative diseases: a focus on human studies.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2015-01-15       Impact factor: 34.870

Review 3.  Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran.

Authors:  Klaus Grossmann
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

4.  Synthetic Aβ peptides acquire prion-like properties in the brain.

Authors:  Xiangzhu Xiao; Ignazio Cali; Jue Yuan; Laura Cracco; Paul Curtiss; Liang Zeng; Mai Abouelsaad; Dimitris Gazgalis; Gong-Xian Wang; Qingzhong Kong; Hisashi Fujioka; Gianfranco Puoti; Wen-Quan Zou
Journal:  Oncotarget       Date:  2015-01-20

5.  pH-Driven Polymorphism of Insulin Amyloid-Like Fibrils.

Authors:  Tomas Sneideris; Domantas Darguzis; Akvile Botyriute; Martynas Grigaliunas; Roland Winter; Vytautas Smirnovas
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

6.  Polymorphism of amyloid-like fibrils can be defined by the concentration of seeds.

Authors:  Tomas Sneideris; Katažyna Milto; Vytautas Smirnovas
Journal:  PeerJ       Date:  2015-08-20       Impact factor: 2.984

Review 7.  Multifaceted Role of Sialylation in Prion Diseases.

Authors:  Ilia V Baskakov; Elizaveta Katorcha
Journal:  Front Neurosci       Date:  2016-08-08       Impact factor: 4.677

8.  Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans.

Authors:  Shu G Chen; Vilius Stribinskis; Madhavi J Rane; Donald R Demuth; Evelyne Gozal; Andrew M Roberts; Rekha Jagadapillai; Ruolan Liu; Kyonghwan Choe; Bhooma Shivakumar; Francheska Son; Shunying Jin; Richard Kerber; Anthony Adame; Eliezer Masliah; Robert P Friedland
Journal:  Sci Rep       Date:  2016-10-06       Impact factor: 4.379

Review 9.  Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development.

Authors:  Gil D Rabinovici; Maria C Carrillo; Mark Forman; Susan DeSanti; David S Miller; Nicholas Kozauer; Ronald C Petersen; Christopher Randolph; David S Knopman; Eric E Smith; Maria Isaac; Niklas Mattsson; Lisa J Bain; James A Hendrix; John R Sims
Journal:  Alzheimers Dement (N Y)       Date:  2016-09-20

10.  Anticoagulants for Treatment of Alzheimer's Disease.

Authors:  Klaus Grossmann
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.